ISR Articles
-
Five Steps To CDMO Selection
10/14/2022
How to establish a plan that identifies outsourcing drivers, select a model that matches company needs and resources, establish a decision-making process and group, and designate key selection criteria.
-
Where Bioprocessing Outsourcers Stand On Capacity Concerns
10/11/2022
Insights into bioprocessing outsourcers’ level of concern regarding current and upcoming available capacity, whether they are currently facing limits, and what they plan to do about a potential shortage.
-
Industry Trends: CDMO Outsourcing
10/5/2022
No single CDMO strategy or outsourcing model is appropriate for every project. Outsourcers can and should evaluate a strategy and partner(s) on a case-by-case basis.
-
Small Molecule Drug Substance Outsourcing Drivers
10/4/2022
ISR asked 57 respondents who outsource small molecule API which reason fits best with their company’s capacity for, and experience with, manufacturing small molecule drug substance. Read how the data shows the most common reason for outsourcing API manufacturing is a lack of capacity despite possessing in-house experience (42%).
-
Biologic Drug Substance Outsourcing Drivers
10/4/2022
ISR data from Q2 2022 shows the most common reason for outsourcing bioprocessing is a lack of capacity despite possessing in-house experience (41%).
-
Understanding The Art And Science Of CRO Selection
9/19/2022
This e-book examines the rationale behind how CROs are selected, why they are retained, and why sponsors opt for one provider or outsourcing model versus another.
-
Top Therapeutic Areas For Highly Potent API
9/13/2022
In Q1 of 2022, ISR asked 100 people who outsource highly potent drug substance what therapeutic areas their medications are designed to target. Discover the most common responses in this survey.
-
Outsourced Bioprocessing By Respondent Location
9/13/2022
Research from ISR finds that a quarter of outsourced bioprocessing efforts are sponsored in America and manufactured in Europe, and vice versa. Delve into how European respondents report outsourcing slightly more bioprocessing to China, while American respondents send more work to Japan and other Asia-Pacific manufacturing facilities (excluding China and India).
-
Industry Trends: Clinical Logistics Outsourcing
8/29/2022
Understanding industry trends, market dynamics, and the selection criteria decision-makers apply when choosing a clinical logistics service provider informs and contextualizes outsourcing decisions.
-
Desired Integrated Clinical Activities
8/15/2022
In Q1 2022, ISR surveyed 100 sponsors who outsource clinical logistics and asked them which activities they would like to source from a single service provider for a trial. Learn why clinical labeling, clinical supply chain management, and storage and distribution of clinical trial materials received the most votes.